Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. - Barakat,R.R.; Wong,G.; Curtin,J.P.; Vlamis,V.; Hoskins,W.J. (Gynecol Oncol, 1994)